Joseph L Minielli

Title: The Innovations of Joseph L. Minielli

Introduction

Joseph L. Minielli, an accomplished inventor based in Evansville, IN, has made significant contributions to the field of pharmaceutical innovation. With a total of four patents to his name, he has developed processes and compositions that enhance therapeutic applications.

Latest Patents

Among his latest patents is the “Process for large-scale production of BMY 21502.” This patent describes an improved synthesis method suitable for adapting to large-scale manufacturing of the cerebral function enhancing agent BMY 21502. Another notable patent is the “Substituted piperidines therapeutic process and compositions,” which involves the creation of heterocyclic compounds of 2-phenethylpiperidines possessing an amido substituent in the ortho position of the phenethyl moiety. These compounds, which include various substituents such as formamido and benzamido, are effective as antiarrhythmic and/or antiserotonin agents, and typical embodiments of this invention showcase innovative chemical structures that hold promise for future therapeutic developments.

Career Highlights

Joseph L. Minielli has had a notable career, working with renowned companies such as Mead Johnson & Company and Bristol-Myers Squibb Company. His expertise and dedicated research in the pharmaceutical field have led to advancements that are crucial for medical science.

Collaborations

Throughout his career, Minielli collaborated with distinguished professionals, including Stanley J. Dykstra and Gary D. Madding. These collaborations have contributed to the innovative nature of his work, leading to breakthroughs in therapeutic processes and drug synthesis.

Conclusion

Joseph L. Minielli’s impact on pharmaceutical innovations is underscored by his patents and collaborations. His work not only highlights his expertise as an inventor but also plays a significant role in the advancement of therapeutic compounds crucial for enhancing human health.